Tag:
Pluvicto
News
Novartis’ Pluvicto: A Breakthrough in the Treatment of Hormone-Sensitive Prostate Cancer
The pharmaceutical company Novartis has published new data from a clinical trial (Phase III PSMAddition). According to the study, the radioligand therapy Pluvicto significantly...